Since CM is a highly immunogenic type of tumor, after discovering that ARL1, ARL11, and ARL15 expression may have a significant impact on CM patients’ prognosis, we investigated whether the immune microenvironment could be involved in the mechanisms associated with ARL prognostic value. The gene discussed is ARL15; the disease is neoplasm.